Neocis Inc. Reaches First Commercial Milestone for Yomi® – The World’s First Robot-Assisted Dental Surgical System
Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced that it reached its first U.S. commercialization milestone with the sale of its 20th Yomi® surgical system.
“Following FDA clearance, we launched the ‘Pioneer Program’ in the U.S. to attract early adopters. I’m extremely pleased with the commercial adoption this program received, enabling us to execute our 20-system sales goal prior to our expected timeline,” said Alon Mozes, PhD, Chief Executive Officer.
Yomi systems purchased under this program were placed with a wide range of customers, including oral surgeons, periodontists, and general dental practices.
“Incorporating Yomi has forever changed the way I place implants. It’s a new level of precision and the next evolution in implant dentistry. Minimally invasive, robot-assisted surgery will soon be the new standard of care in implantology,” said Eddie Kotary, DMD.
There are more than four million dental implants performed each year in the U.S. Yet conventional surgery and drill guides fail to address many procedural challenges, such as invasive incisions and nerve damage from misplaced implants. In addition, dental implant surgeries are shifting from specialists to general dentists. Neocis’ Yomi surgical system provides the critical planning and guidance features that provide dental surgeons with the ability to gain real-time visual feedback and physical haptic guidance, which enables a minimally invasive flapless approach.